Phylodynamic analysis in the understanding of the current COVID-19 pandemic and its utility in vaccine and antiviral design and assessment

References

• Rife BD, Mavian C, Chen X, Ciccozzi M, Salemi M, Min J, Prosperi MC. Phylodynamic applications in 21(st) century global infectious disease research. Glob Health Res Policy. 2017;2:13. doi:10.1186/s41256-017-0034-y.
   PubMedGoogle Scholar
• Holmes EC. Evolutionary history and phylogeography of human viruses. Annu Rev Microbiol. 2008;62:307–28. doi:10.1146/annurev.micro.62.081307.162912.
   PubMed Web of Science ®Google Scholar
• Ojosnegros S, Beerenwinkel N. Models of RNA virus evolution and their roles in vaccine design. Immunome Res. 2010;6(Suppl 2):S5. doi:10.1186/1745-7580-6-S2-S5.
   PubMedGoogle Scholar
• Templeton AR. Genetic drift in large populations and coalescence. Populat Gen Microevolution Theory. 2006;118–67.
   Google Scholar
• Biswas NK, Majumder PP. Analysis of RNA sequences of 3636 SARS-CoV-2 collected from 55 countries reveals selective sweep of one virus type. Indian J Med Res. 2020;151:450–58. doi:10.4103/ijmr.IJMR_1125_20.
   PubMed Web of Science ®Google Scholar
• Nie Q, Li X, Chen W, Liu D, Chen Y, Li H, Li D, Tian M, Tan W, Zai J, et al. Phylogenetic and phylodynamic analyses of SARS-CoV-2. Virus Res. 2020;287:198098. doi:10.1016/j.virusres.2020.198098.
   PubMed Web of Science ®Google Scholar
• Sironi M, Hasnain SE, Rosenthal B, Phan T, Luciani F, Shaw MA, Sallum MA, Mirhashemi ME, Morand S, González-Candelas F, et al. SARS-CoV-2 and COVID-19: a genetic, epidemiological, and evolutionary perspective. Infect Genet Evol. 2020;84:104384. doi:10.1016/j.meegid.2020.104384.
   PubMed Web of Science ®Google Scholar
• Volz EM, Koelle K, Bedford T. Viral phylodynamics. PLoS Comput Biol. 2013;9:e1002947. doi:10.1371/journal.pcbi.1002947.
   PubMed Web of Science ®Google Scholar
• Benvenuto D, Giovanetti M, Salemi M, Prosperi M, De Flora C, Junior Alcantara LC, Angeletti S, Ciccozzi M. The global spread of 2019-nCoV: a molecular evolutionary analysis. Pathog Glob Health. 2020;114:64–67. doi:10.1080/20477724.2020.1725339.
   PubMed Web of Science ®Google Scholar
• Grenfell BT, Pybus OG, Gog JR, Wood JL, Daly JM, Mumford JA, Holmes EC. Unifying the epidemiological and evolutionary dynamics of pathogens. Sci. 2004;303:327–32. doi:10.1126/science.1090727.
   PubMed Web of Science ®Google Scholar
• Lei N, Wang HB, Zhang YS, Zhao JH, Zhong Y, Wang YJ, Huang L-Y, Ma J-X, Sun Q, Yang L, et al. Molecular evolution of influenza B virus during 2011-2017 in Chaoyang, Beijing, suggesting the free influenza vaccine policy. Sci Rep. 2019;9:2432. doi:10.1038/s41598-018-38105-1.
   PubMed Web of Science ®Google Scholar
• Bush RM, Bender CA, Subbarao K, Cox NJ, Fitch WM. Predicting the evolution of human influenza A. Science. 1999;286:1921–25. doi:10.1126/science.286.5446.1921.
   PubMed Web of Science ®Google Scholar
• GISAID. Genomic epidemiology of novel coronavirus; 2020. [accessed 2020 Nov 05]. https://nextstrain.org/ncov
   Google Scholar
• Shu Y, McCauley J. GISAID: global initiative on sharing all influenza data - from vision to reality. Euro Surveill. 2017;22(13):30494.
   Google Scholar
• Elbe S, Buckland-Merrett G. Data, disease and diplomacy: GISAID’s innovative contribution to global health. Glob Chall. 2017;1:33–46. doi:10.1002/gch2.1018.
   PubMedGoogle Scholar
• Rodriguez-Morales AJ, Balbin-Ramon GJ, Rabaan AA, Sah R, Dhama K, Paniz-Mondolfi A, Pagliano P, Esposito S. Genomic epidemiology and its importance in the study of the COVID-19 pandemic. Infez Med. 2020;28:139–42.
   PubMedGoogle Scholar
• Evans AS. Viral infections of humans: epidemiology and control. Springer Sci Business Media. 2013.
   Google Scholar
• Azuma K, Yanagi U, Kagi N, Kim H, Ogata M, Hayashi M. Environmental factors involved in SARS-CoV-2 transmission: effect and role of indoor environmental quality in the strategy for COVID-19 infection control. Environ Health Prev Med. 2020;25:66. doi:10.1186/s12199-020-00904-2.
   PubMed Web of Science ®Google Scholar
• Kuhnert D, Stadler T, Vaughan TG, Drummond AJ. Simultaneous reconstruction of evolutionary history and epidemiological dynamics from viral sequences with the birth-death SIR model. J R Soc Interface. 2014;11:20131106. doi:10.1098/rsif.2013.1106.
   PubMed Web of Science ®Google Scholar
• Volz EM, Siveroni I. Bayesian phylodynamic inference with complex models. PLoS Comput Biol. 2018;14:e1006546. doi:10.1371/journal.pcbi.1006546.
   PubMed Web of Science ®Google Scholar
• Volz EM, Romero-Severson E, Leitner T. Phylodynamic Inference across Epidemic Scales. Mol Biol Evol. 2017;34:1276–88. doi:10.1093/molbev/msx077.
   PubMed Web of Science ®Google Scholar
• Volz E, Frost S. Scalable relaxed clock phylogenetic dating. Virus Evolution. 2017;3. doi:10.1093/ve/vex014.
   Web of Science ®Google Scholar
• Bouckaert R, Vaughan TG, Barido-Sottani J, Duchêne S, Fourment M, Gavryushkina A, Heled J, Jones G, Kühnert D, De Maio N, et al. BEAST 2.5: an advanced software platform for Bayesian evolutionary analysis. PLoS Comput Biol. 2019;15(4):e1006650. doi:10.1371/journal.pcbi.1006650.
   PubMed Web of Science ®Google Scholar
• Drummond AJ, Pybus OG, Rambaut A, Forsberg R, Rodrigo AG. Measurably evolving populations. Trends Ecol Evol. 2003;18:481–88. doi:10.1016/S0169-5347(03)00216-7.
   Web of Science ®Google Scholar
• Magiorkinis G, Sypsa V, Magiorkinis E, Paraskevis D, Katsoulidou A, Belshaw R, Fraser C, Pybus OG, Hatzakis A, et al. Integrating phylodynamics and epidemiology to estimate transmission diversity in viral epidemics. PLoS Comput Biol. 2013;9:e1002876–e. doi:10.1371/journal.pcbi.1002876.
   PubMed Web of Science ®Google Scholar
• Rasmussen DA, Boni MF, Koelle K. Reconciling phylodynamics with epidemiology: the case of dengue virus in southern Vietnam. Mol Biol Evol. 2014;31:258–71. doi:10.1093/molbev/mst203.
   PubMed Web of Science ®Google Scholar
• Volz E, Baguelin M, Bhatia S, Boonyasiri A, Cori A, Cucunubá Z, Cuomo-Dannenburg G, Donnelly CA, Dorigatti I, FitzJohn R. Report 5: Phylogenetic analysis of SARS-CoV-2.
   Google Scholar
• Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199–207. doi:10.1056/NEJMoa2001316.
   PubMed Web of Science ®Google Scholar
• Park M, Cook AR, Lim JT, Sun Y, Dickens BL. A systematic review of COVID-19 epidemiology based on current evidence. J Clin Med. 2020;9(4):967.
   Web of Science ®Google Scholar
• Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020;395:689–97. doi:10.1016/S0140-6736(20)30260-9.
   PubMed Web of Science ®Google Scholar
• Rojas-Gallardo DM, Garzon-Castano SC, Millan N, Jimenez-Posada EV, Martinez-Gutierrez M, Ruiz-Saenz J, Cardona-Ospina JA. COVID-19 in Latin America: contrasting phylodynamic inference with epidemiological surveillance. (Molecular epidemiology of COVID-19 in Latin America). medRxiv 2020; 2020.05.23.20111443.
   Google Scholar
• Seemann T, Lane CR, Sherry NL, Duchene S, Gonçalves da Silva A, Caly L, Sait M, Ballard SA, Horan K, Schultz MB, et al. Tracking the COVID-19 pandemic in Australia using genomics. Nat Commun. 2020;11:4376. doi:10.1038/s41467-020-18314-x.
   PubMed Web of Science ®Google Scholar
• Candido DS, Claro IM, de Jesus JG, Souza WM, Moreira FRR, Dellicour S, Mellan TA, du Plessis L, Pereira RHM, Sales FCS, et al. Evolution and epidemic spread of SARS-CoV-2 in Brazil. Science. 2020; 369:1255–60.
   Google Scholar
• Lemey P, Hong S, Hill V, Baele G, Poletto C, Colizza V, et al. Accommodating individual travel history, global mobility, and unsampled diversity in phylogeography: a SARS-CoV-2 case study. bioRxiv. 2020.
   Google Scholar
• Ciccozzi M, Lai A, Zehender G, Borsetti A, Cella E, Ciotti M, Sagnelli E, Sagnelli C, Angeletti S. The phylogenetic approach for viral infectious disease evolution and epidemiology: an updating review. J Med Virol. 2019;91:1707–24. doi:10.1002/jmv.25526.
   PubMed Web of Science ®Google Scholar
• Mandary MB, Masomian M, Poh CL. Impact of RNA virus evolution on Quasispecies formation and virulence. Int J Mol Sci. 2019;20. doi:10.3390/ijms20184657.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Li H, Wu X, Zhong Y, Zhang K, Zhang Y-P, Boerwinkle E, Fu Y-X. Moderate mutation rate in the SARS coronavirus genome and its implications. BMC Evol Biol. 2004;4:21. doi:10.1186/1471-2148-4-21.
   PubMed Web of Science ®Google Scholar
• Eckerle LD, Becker MM, Halpin RA, Li K, Venter E, Lu X, Scherbakova S, Graham RL, Baric RS, Stockwell TB, et al. Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing. PLoS Pathog. 2010;6(5):e1000896. doi:10.1371/journal.ppat.1000896.
   PubMed Web of Science ®Google Scholar
• Duffy S, Shackelton LA, Holmes EC. Rates of evolutionary change in viruses: patterns and determinants. Nat Rev Genet. 2008;9:267–76. doi:10.1038/nrg2323.
   PubMed Web of Science ®Google Scholar
• Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W, Hengartner N, Giorgi EE, Bhattacharya T, Foley B, et al. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182(4):812–27.e19. doi:10.1016/j.cell.2020.06.043.
   PubMed Web of Science ®Google Scholar
• van Dorp L, Acman M, Richard D, Shaw LP, Ford CE, Ormond L, Owen CJ, Pang J, Tan CCS, Boshier FAT, et al. Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. Infect Genet Evol. 2020:104351. doi:10.1016/j.meegid.2020.104351.
   PubMed Web of Science ®Google Scholar
• Laha S, Chakraborty J, Das S, Manna SK, Biswas S, Chatterjee R. Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission. Infect Genet Evol. 2020;85:104445. doi:10.1016/j.meegid.2020.104445.
   PubMed Web of Science ®Google Scholar
• Weisblum Y, Schmidt F, Zhang F, DaSilva J, Poston D, Lorenzi JC, Muecksch F, Rutkowska M, Hoffmann -H-H, Michailidis E, et al. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. Elife. 2020;9:e61312. doi:10.7554/eLife.61312.
   PubMed Web of Science ®Google Scholar
• Li Q, Wu J, Nie J, Zhang L, Hao H, Liu S, Zhao C, Zhang Q, Liu H, Nie L, et al. The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity. Cell. 2020;182(5):1284–94 e9. doi:10.1016/j.cell.2020.07.012.
   PubMed Web of Science ®Google Scholar
• Koyama T, Weeraratne D, Snowdon JL, Parida L. Emergence of drift variants that may affect COVID-19 vaccine development and antibody treatment. Pathogens. 2020;9:324. doi:10.3390/pathogens9050324.
   PubMed Web of Science ®Google Scholar
• Rosenberg NA, Nordborg M. Genealogical trees, coalescent theory and the analysis of genetic polymorphisms. Nat Rev Genet. 2002;3:380–90. doi:10.1038/nrg795.
   PubMed Web of Science ®Google Scholar
• Nayak MK, Banerjee A, Sarkar R, Mitra S, Dutta K, Ganguly N, Ghosh C, Girish Kumar CP, Niyogi P, Panda S, et al. Genetic characterization of group-A rotaviruses among children in eastern India during 2014–2016: phylodynamics of co-circulating genotypes. Vaccine. 2019;37(45):6842–56. doi:10.1016/j.vaccine.2019.06.062.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Draft landscape of COVID-19 candidate vaccines. Geneva (Switzerland): World Health Organization; 2020.
   Google Scholar
• Thanh Le T, Andreadakis Z, Kumar A, Gomez Roman R, Tollefsen S, Saville M, Mayhew S. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19(5):305–06. doi:10.1038/d41573-020-00073-5.
   PubMed Web of Science ®Google Scholar
• Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, Guo L, Guo R, Chen T, Hu J, et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun. 2020;11(1):1620. doi:10.1038/s41467-020-15562-9.
   PubMed Web of Science ®Google Scholar
• Yin C. Genotyping coronavirus SARS-CoV-2: methods and implications. Genomics. 2020;112:3588–96. doi:10.1016/j.ygeno.2020.04.016.
   PubMed Web of Science ®Google Scholar
• Rogers TF, Zhao F, Huang D, Beutler N, Burns A, He WT, Limbo O, Smith C, Song G, Woehl J, et al. Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science. 2020;369:956–63. doi:10.1126/science.abc7520.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Wang N, Ou X. Caution should be exercised for the detection of SARS-CoV-2, especially in the elderly. J Med Virol. 2020;92(9):1641–48. doi:10.1002/jmv.25796.
   PubMed Web of Science ®Google Scholar
• Xiao AT, Tong YX, Zhang S. False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: rather than recurrence. J Med Virol. 2020;92(10):1755–56. doi:10.1002/jmv.25855.
   PubMed Web of Science ®Google Scholar
• Xiang F, Wang X, He X, Peng Z, Yang B, Zhang J, Zhou Q, Ye H, Ma Y, Li H, et al. Antibody detection and dynamic characteristics in patients with COVID-19. Clin Infect Dis. 2020;71(8):1930–34. doi:10.1093/cid/ciaa461.
   PubMed Web of Science ®Google Scholar
• Peng J, Wang M, Zhang G, Lu E. Seven discharged patients turning positive again for SARS-CoV-2 on quantitative RT-PCR. Am J Infect Control. 2020;48(6):725–26. doi:10.1016/j.ajic.2020.03.017.
   PubMed Web of Science ®Google Scholar
• Okba NMA, Muller MA, Li W, Wang C, GeurtsvanKessel CH, Corman VM, Lamers MM, Sikkema RS, de Bruin E, Chandler FD, et al. Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease 2019 patients. Emerg Infect Dis. 2020;26(7):1478–88.
   Google Scholar
• Diaz-Quijano FA, Rodriguez-Morales AJ, Waldman EA. Translating transmissibility measures into recommendations for coronavirus prevention. Rev Saude Publica. 2020;54:43. doi:10.11606/s1518-8787.2020054002471.
   PubMed Web of Science ®Google Scholar
• Ke R, Li H, Wang S, Ding W, Ribeiro RM, EE G, Bhattacharya T, Barnard RJO, Hahn BH, Shaw GM, et al. Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistence. Proc Natl Acad Sci U S A. 2018;115:E7139. doi:10.1073/pnas.1805267115.
   PubMed Web of Science ®Google Scholar
• Capobianchi MR, Rueca M, Messina F, Giombini E, Carletti F, Colavita F, et al. Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy. Clin Microbiol Infect. 2020;26(7):954–56.
   Web of Science ®Google Scholar
• Beerenwinkel N, Daumer M, Sing T, Rahnenfuhrer J, Lengauer T, Selbig J, Hoffmann D, Kaiser R. Estimating HIV evolutionary pathways and the genetic barrier to drug resistance. J Infect Dis. 2005;191:1953–60. doi:10.1086/430005.
   PubMed Web of Science ®Google Scholar
• Beerenwinkel N, Lengauer T, Daumer M, Kaiser R, Walter H, Korn K, Hoffmann D, Selbig J. Methods for optimizing antiviral combination therapies. Bioinformatics. 2003;19(Suppl 1):i16–25. doi:10.1093/bioinformatics/btg1001.
   PubMedGoogle Scholar
• Andreakos E, Tsiodras S. COVID-19: lambda interferon against viral load and hyperinflammation. EMBO Mol Med. 2020. doi:10.15252/emmm.202012465.
   PubMed Web of Science ®Google Scholar
• Diurno F, Numis FG, Porta G, Cirillo F, Maddaluno S, Ragozzino A, De Negri P, Di Gennaro C, Pagano A, Allegorico E, et al. Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience. Eur Rev Med Pharmacol Sci. 2020;24:4040–47. doi:10.26355/eurrev_202004_20875.
   PubMed Web of Science ®Google Scholar
• Abena PM, Decloedt EH, Bottieau E, Suleman F, Adejumo P, Sam-Agudu NA, Muyembe TamFum -J-J, Seydi M, Eholie SP, Mills EJ, et al. Chloroquine and hydroxychloroquine for the prevention or treatment of novel coronavirus disease (COVID-19) in Africa: caution for inappropriate off-label use in healthcare settings. Am J Trop Med Hyg. 2020;102(6):1184–88. doi:10.4269/ajtmh.20-0290.
   PubMed Web of Science ®Google Scholar
• Borba MGS, Val FFA, Sampaio VS, Alexandre MAA, Melo GC, Brito M, Mourão MPG, Brito-Sousa JD, Baía-da-Silva D, Guerra MVF, et al. Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial. JAMA Netw Open. 2020;3:e208857. doi:10.1001/jamanetworkopen.2020.8857.
   PubMed Web of Science ®Google Scholar
• Costanzo M, De Giglio MAR, Roviello GN. SARS-CoV-2: recent reports on antiviral therapies based on lopinavir/ ritonavir,darunavir/ umifenovir,hydroxychloroquine, remdesivir, favipiravir and other drugs for the treatment of the new coronavirus. Curr Med Chem. 2020. doi:10.2174/0929867327666200416131117.
   PubMed Web of Science ®Google Scholar
• Damle B, Vourvahis M, Wang E, Leaney J, Corrigan B. Clinical pharmacology perspectives on the antiviral activity of azithromycin and use in COVID-19. Clin Pharmacol Ther. 2020;108(2):201–11. doi:10.1002/cpt.1857.
   PubMed Web of Science ®Google Scholar
• Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y. The epidemiology, diagnosis and treatment of COVID-19. Int J Antimicrob Agents. 2020;55(5):105955. doi:10.1016/j.ijantimicag.2020.105955.
   PubMed Web of Science ®Google Scholar
• Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269–71. doi:10.1038/s41422-020-0282-0.
   PubMed Web of Science ®Google Scholar
• Felsenstein S, Herbert JA, McNamara PS, Hedrich CM. COVID-19: immunology and treatment options. J Clin Immunol. 2020;215:108448. doi:10.1016/j.clim.2020.108448.
   Google Scholar
• Frost SDW, Volz EM. Viral phylodynamics and the search for an ‘effective number of infections’. Philos Trans R Soc Lond B Biol Sci. 2010;365:1879–90. doi:10.1098/rstb.2010.0060.
   PubMed Web of Science ®Google Scholar
• Meriki HD, Tufon KA, Anong DN, Atanga PN, Anyangwe IA, Cho-Ngwa F, et al. Genetic diversity and antiretroviral resistance-associated mutation profile of treated and naive HIV-1 infected patients from the Northwest and Southwest regions of Cameroon. PLoS One. 2019;14:e0225575. doi:10.1371/journal.pone.0225575.
   PubMed Web of Science ®Google Scholar
• Perez-Losada M, Castel AD, Lewis B, Kharfen M, Cartwright CP, Huang B, et al. Characterization of HIV diversity, phylodynamics and drug resistance in Washington, DC. PLoS One. 2017;12:e0185644. doi:10.1371/journal.pone.0185644.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Morales AJ, Rodriguez-Morales AG, Méndez CA, Hernández-Botero S. Tracing new clinical manifestations in patients with COVID-19 in Chile and its potential relationship with the SARS-CoV-2 divergence. Curr Trop Med Rep. 2020;18:1–4.
   Google Scholar
• Sah R, Rodriguez-Morales AJ, Jha R, Chu DKW, Gu H, Peiris M, et al. Complete genome sequence of a 2019 novel coronavirus (SARS-CoV-2) strain isolated in Nepal. Microbiol Resour Announc. 2020:9. doi:10.1128/MRA.00169-20.
   Google Scholar